NNC0519-0130
A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or Obesity
Novo Nordisk · Phase 1 · Completed · Enrollment 134
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Arm 1: NNC0519-0130 | n/r | n/r | n/r | n/r |
| Arm 2: NNC0519-0130 | n/r | n/r | n/r | n/r |
| Arm 3: NNC0519-0130 | n/r | n/r | n/r | n/r |
| Arm 4: NNC0519-0130 | n/r | n/r | n/r | n/r |
Not shown
- Arm 1: NNC0519-0130: endpoint not reported
- Arm 2: NNC0519-0130: endpoint not reported
- Arm 3: NNC0519-0130: endpoint not reported
- Arm 4: NNC0519-0130: endpoint not reported